🔎 Trials Near Me

Inicio › Cáncer de ovario › Florida

Ensayos clínicos de Cáncer de ovario en Florida

83 estudios sobre Cáncer de ovario buscan participantes en Florida.

Ciudades en Florida

Texto oficial del estudio (inglés)

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

  • UF Health Cancer Institute - Gainesville, Gainesville
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 nov 2026 · NCT07001748

A Phase I/II, First-in-Human Study to Evaluate TJ102 in Participants With Advanced or Metastatic Ovarian Cancer and Other Solid Tumors.

  • Florida Cancer Specialists Lake Nona, Orlando
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT07778498

Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer

  • Advent Health, Orlando
ReclutandoFase 3
Edades de 18 en adelante · Mujeres · Actualizado el 12 nov 2026 · NCT06915025

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  • UM Sylvester Comprehensive Cancer Center at Aventura, Aventura
  • UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
  • UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
  • y 6 más
ReclutandoFase 2
Todas las edades · Todos los sexos · Actualizado el 12 nov 2026 · NCT05564377

A Clinical Trial of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab in Participants With Ovarian Cancer Who Have Progressed During Treatment With PARP-inhibitors Treatment on First Line Maintenance (MK-5909-008/ENGOT-ov107/GOG-3142 / REJOICE-Ovarian05)

  • Orlando Health Cancer Institute ( Site 0018), Orlando
ReclutandoFase 3
Edades de 18 en adelante · Mujeres · Actualizado el 10 nov 2026 · NCT07743164

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

  • Mount Sinai Braman Comprehensive Cancer Center ( Site 0078), Miami Beach
  • Sarasota Memorial Hospital ( Site 0075), Sarasota
  • Florida Cancer Specialists East ( Site 7000), West Palm Beach
ReclutandoFase 3
Edades de 18 en adelante · Mujeres · Actualizado el 10 nov 2026 · NCT06824467

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

  • Mount Sinai Cancer Center ( Site 0029), Miami Beach
  • Orlando Health Winnie Palmer Hospital for Women and Babies ( Site 0085), Orlando
ReclutandoFase 3
Edades de 18 en adelante · Mujeres · Actualizado el 10 nov 2026 · NCT07318558

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

  • Holy Cross Hospital, Fort Lauderdale
  • Broward Health Medical Center, Fort Lauderdale
  • UF Health Cancer Institute - Gainesville, Gainesville
  • y 5 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 nov 2026 · NCT06580314

A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression

  • Site 0116, Orlando
ReclutandoFase 3
Edades de 18 en adelante · Mujeres · Actualizado el 9 nov 2026 · NCT07546500

Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Non-Homologous Recombination Deficiency (Non-HRD) Positive Advanced Epithelial Ovarian Cancer

  • Research Site, Tamarac
  • Research Site, Tampa
ReclutandoFase 3
Edades de 18 en adelante · Mujeres · Actualizado el 6 nov 2026 · NCT07851025

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

  • Mayo Clinic Jacksonville, Jacksonville
  • University of Miami Sylvester Comprehensive Cancer Center, Miami
  • Advent Health Cancer Institute, Orlando
  • y 1 más
ReclutandoFase 2
Edades de 18 en adelante · Mujeres · Actualizado el 6 nov 2026 · NCT06787612

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

  • UM Sylvester Comprehensive Cancer Center at Aventura, Aventura
  • Florida Cancer Specialists - Bradenton Cancer Center, Bradenton
  • Morton Plant Hospital, Clearwater
  • y 26 más
Reclutando
Edades de 35 a 50 · Mujeres · Actualizado el 6 nov 2026 · NCT04251052

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

  • AdventHealth Cancer Institute, Orlando
ReclutandoFase 1
Edades de 19 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT06586957

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

  • Mayo Clinic, Jacksonville
  • Genoma Research, Inc., Miami
  • Orlando Health, Orlando
  • y 1 más
ReclutandoEstudio observacional
Edades de 18 en adelante · Mujeres · Actualizado el 5 nov 2026 · NCT05051722

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

  • Broward Health Medical Center, Fort Lauderdale
  • Florida Cancer Specialist- South, Fort Myers
  • Baptist MD Anderson Cancer Center, Jacksonville
  • y 5 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07213804

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

  • USOR Florida Cancer Specialists South, Fort Myers
  • USOR Florida Cancer Specialists North, St. Petersburg
  • USOR Florida Cancer Specialists East, West Palm Beach
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT05579366

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

  • Moffitt, Tampa
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07213791

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

  • Florida Cancer Specialists & Research Institute - Fort Myers Cancer Center - Gladiolus, Fort Myers
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06760819

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

  • Site 0241 - Florida Cancer Specialist - North, Altamonte Springs
  • Site 0173 - Mount Sinai Medical Center, Miami Beach
  • Site 0308 - Advent Health, Orlando
  • y 1 más
ReclutandoFase 2
Edades de 18 en adelante · Mujeres · Actualizado el 30 oct 2026 · NCT05128825

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

  • USA08-0, Florida City
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 oct 2026 · NCT06953089

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

  • Florida Cancer Specialists - Lake Nona, Orlando
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 oct 2026 · NCT07109726

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

  • Broward Health Medical Center, Fort Lauderdale
  • Jupiter Medical Center, Jupiter
  • Mount Sinai Medical Center, Miami Beach
  • y 2 más
ReclutandoFase 3
Edades de 18 en adelante · Mujeres · Actualizado el 28 oct 2026 · NCT06819007

Lead-212 PSV359 Therapy for Patients With Solid Tumors

  • University of Miami, Miami
  • Biogenix, Miami
ReclutandoFase 1/2
Edades de 18 a 90 · Todos los sexos · Actualizado el 28 oct 2026 · NCT06710756

A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

  • Florida Cancer Specialists, Lake Mary
  • Sylvester Cancer Center, Miami
  • Mount Sinai Comprehensive Cancer Center, Miami Beach
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 26 oct 2026 · NCT06161025

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

  • Mayo Clinic Jacksonville, Jacksonville
  • Moffitt Cancer Center, Tampa
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 26 oct 2026 · NCT04981119

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • AdventHealth Medical Group Oncology Research at Celebration, Kissimmee
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 26 oct 2026 · NCT06172478

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

  • Florida Cancer Specialists, Fort Myers
  • Mayo Clinic (Florida), Jacksonville
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 oct 2026 · NCT04657068

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

  • Jupiter Medical Center /ID# 276616, Jupiter
ReclutandoFase 2
Edades de 18 en adelante · Mujeres · Actualizado el 20 oct 2026 · NCT06890338

Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer

  • Research Site, Miami
ReclutandoFase 3
Edades de 18 en adelante · Mujeres · Actualizado el 16 oct 2026 · NCT07816666

A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9

  • Florida Cancer Specialists, Orlando
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 15 oct 2026 · NCT07186842

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

  • Sylvester Comprehensive Cancer Center - University of Miami Health System, Miami
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 15 oct 2026 · NCT06239194

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

  • Mount Sinai Medical Center Comprehensive Cancer Center, Miami Beach
ReclutandoFase 3
Edades de 18 en adelante · Mujeres · Actualizado el 15 oct 2026 · NCT07214779

A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer

  • University of Florida College of Medicine /ID# 278348, Gainesville
  • Orlando Health Cancer Institute Gynecologic Cancer Center - Orlando /ID# 278623, Orlando
  • Florida Cancer Specialists - North /ID# 278626, St. Petersburg
  • y 1 más
ReclutandoFase 2
Edades de 18 en adelante · Mujeres · Actualizado el 13 oct 2026 · NCT07059845

First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer

  • Florida Cancer Specialists, Sarasota
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 oct 2026 · NCT06799065

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

  • University of Miami, Miami
  • Sarah Cannon Research Institute - Lake Nona Florida, Orlando
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 oct 2026 · NCT06293898

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

  • Moffitt Cancer Center, Tampa
ReclutandoFase 1
Edades de 15 en adelante · Todos los sexos · Actualizado el 9 oct 2026 · NCT06276491

Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women

  • Sylvester Comprehensive Cancer Center, Univ of Miami Miller School of Medicine, Miami
ReclutandoSe aceptan voluntarios sanos
Edades de 50 a 74 · Mujeres · Actualizado el 9 oct 2026 · NCT00539162

Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy

  • Mt. Sinai Comprehensive Cancer Center, Miami
  • Sarasota Memorial Health Care System, Sarasota
ReclutandoFase 3
Edades de 18 en adelante · Mujeres · Actualizado el 6 oct 2026 · NCT07225270

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • University of Miami - Sylvester Comprehensive Cancer Center, Miami
  • Advent Health, Orlando
  • Florida Cancer Specialists South, Port Charlotte
ReclutandoFase 1/2
Edades de 12 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT04585750

The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas

  • Mayo Clinic in Florida, Jacksonville
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT07285044

De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.